Although some prostate cancer cell lines, such as VCaP (ERG) and LNCaP (ETV1) are reported to have oncogenic ETS gene rearrangements [11,14], the full extent of oncogenic ETS protein expression, including fusion-independent expression, in commonly used prostate cancer cell lines has not been determined. The gene discussed is ERG; the disease is prostate carcinoma.